Cold sores are caused by certain strains of the herpes simplex virus (HSV). HSV-1 usually causes cold sores. HSV-2 is usually responsible for genital herpes. However, either type can cause sores in the facial area or on the genitals. Most people who are infected with the virus that causes cold sores never develop signs and symptoms. The herpes simplex virus usually enters the body through a break in the skin around or inside the mouth. It is usually spread when a person touches a cold sore or touches infected fluid-such as from sharing eating utensils or razors, kissing an infected person, or touching that person's saliva. A parent who has a cold sore often spreads the infection to his or her child in this way. Cold sores can also be spread to other areas of the body. In Poland the overall prevalences of type specific HSVâ1 and HSVâ2 serum antibodies were 90.4% and 9.3%, respectively. Age standardised HSVâ2 seroprevalence was higher in women (9.7%) than men (8.8%) (pâ=â0.06), and increased notably with age from 4% in 15–24 year olds to 12% in those aged 50–65 years. HSVâ1 seroprevalence was consistently higher than HSVâ2 seroprevalence in each specific age group, ranging from 74.5% in 15–24 year olds to 98.8% in 50–65 year olds. HSVâ2 seroprevalence varied significantly by geographical region, with the highest prevalence in the Zachodnioâpomorskie district (12%). Significant multivariate risk factors for HSVâ2 seropositivity included older age, female gender, and geographical place of residence. Cold sores usually clear up without treatment within 7 to 10 days.
Antiviral tablets or cream can be used to ease your symptoms and speed up the healing time. Antiviral creams such as aciclovir or penciclovir (also known as Fenistil) may speed up the healing time of a recurrent cold sore infection if used correctly.Cold sore creams are widely available over the counter from pharmacies without a prescription. They are only effective if you apply them as soon as the first signs of a cold sore appear, when the herpes simplex virus is spreading and replicating. Using an antiviral cream after this initial period is unlikely to have much effect. Cold sore patches that contain a special gel called hydrocolloid are also available. They are an effective treatment for skin wounds and are placed over the cold sore to hide the sore area while it heals Various vaccine candidates have been developed, the first ones in the 1920s, but none has been successful to date. Due to the genetic similarity of both herpes simplex virus types (HSV-1 and HSV-2), the development of a prophylactic-therapeutic vaccine which is proven effective against one type of the virus would provide fundamentals for vaccine-development for the other virus type. As of 2015, several vaccine candidates are in different stages of clinical trials as they are being tested for safety and efficacy, including at least three vaccine candidates in the US and one in Australia.